Sara Cuadrado Castano, PhD
img_Sara Cuadrado Castano
Research Topics
Anti-Tumor Therapy, Antigen Presentation, Apoptosis/Cell Death, Autophagy, Biochemistry, Biomedical Sciences, Breast Cancer, Cancer, Cellular Immunity, Chemokines, Chemotaxis, Cytokines, Dendritic Cells, Education, Gene Therapy, Immune Antagonism, Immunology, Infectious Disease, Inflammation, Influenza Virus, Interferon, Interferon Antagonists, Interferon Resistance, Knockout Mice, Lung, Lymphoma, Macrophage, Metastasis, Skin Cancer, T Cells, Technology & Innovation, Translational Research, Virulence Genes, Viruses and Virology
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM], Microbiology [MIC]

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Cuadrado Castano during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Accurius Therapeutics, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.